What is known about patients' quality of life with Phenylketonuria and their caregivers? A scoping review

Eduardo Remor,Kamilla Mueller Gabe,Katia Irie Teruya,Ida Vanessa Doederlein Schwartz
DOI: https://doi.org/10.1186/s13023-024-03422-4
2024-10-31
Orphanet Journal of Rare Diseases
Abstract:Phenylketonuria (PKU) is a rare genetic disorder characterized by a deficiency in the metabolism of the essential amino acid phenylalanine, which has a neurotoxic effect at high concentrations. The available treatment for PKU involves limiting the intake of phenylalanine through a restrictive diet. Strict adherence to treatment is essential for a child's proper development. Owing to their rare and chronic condition, PKU patients and their caregivers need to address many specific challenges, which can affect their quality of life (QoL).
genetics & heredity,medicine, research & experimental
What problem does this paper attempt to address?